253 related articles for article (PubMed ID: 27027662)
21. Incidence and control of steroid-induced hyperglycaemia in hospitalised patients at a tertiary care centre for lung diseases.
Dobravc Verbič M; Gruban J; Kerec Kos M
Pharmacol Rep; 2021 Jun; 73(3):796-805. PubMed ID: 33651365
[TBL] [Abstract][Full Text] [Related]
22. The role of glucagon in the endogenous hyperglycemia of diabetes mellitus.
Unger RH; Orci L
Annu Rev Med; 1977; 28():119-30. PubMed ID: 324351
[No Abstract] [Full Text] [Related]
23. Clinical potential of insulin therapy in critically ill patients.
Mesotten D; Van den Berghe G
Drugs; 2003; 63(7):625-36. PubMed ID: 12656643
[TBL] [Abstract][Full Text] [Related]
24. The insulin-antagonistic effect of the counterregulatory hormones.
Lager I
J Intern Med Suppl; 1991; 735():41-7. PubMed ID: 2043222
[TBL] [Abstract][Full Text] [Related]
25. The role of dysregulated glucagon secretion in type 2 diabetes.
D'Alessio D
Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():126-32. PubMed ID: 21824266
[TBL] [Abstract][Full Text] [Related]
26. On the role of the gut in diabetic hyperglucagonaemia.
Lund A
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175
[TBL] [Abstract][Full Text] [Related]
27. [The physiology of glucagon-like peptide-1 and its role in the pathophysiology of type 2 diabetes mellitus].
Escalada FJ
Med Clin (Barc); 2014 Sep; 143 Suppl 2():2-7. PubMed ID: 25437458
[TBL] [Abstract][Full Text] [Related]
28. Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a review.
Østergaard L; Frandsen CS; Madsbad S
Expert Rev Clin Pharmacol; 2016; 9(2):241-65. PubMed ID: 26573176
[TBL] [Abstract][Full Text] [Related]
29. The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications.
Dunning BE; Gerich JE
Endocr Rev; 2007 May; 28(3):253-83. PubMed ID: 17409288
[TBL] [Abstract][Full Text] [Related]
30. Glucagon and hyperglycaemia in diabetes.
Cryer PE
Clin Sci (Lond); 2008 May; 114(9):589-90. PubMed ID: 18197838
[TBL] [Abstract][Full Text] [Related]
31. Islet α cells and glucagon--critical regulators of energy homeostasis.
Campbell JE; Drucker DJ
Nat Rev Endocrinol; 2015 Jun; 11(6):329-38. PubMed ID: 25850661
[TBL] [Abstract][Full Text] [Related]
32. Stress-Induced Hyperglycemia: Consequences and Management.
Vedantam D; Poman DS; Motwani L; Asif N; Patel A; Anne KK
Cureus; 2022 Jul; 14(7):e26714. PubMed ID: 35959169
[TBL] [Abstract][Full Text] [Related]
33. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
[TBL] [Abstract][Full Text] [Related]
34. A review of stress-induced hyperglycaemia in the context of acute ischaemic stroke: Definition, underlying mechanisms, and the status of insulin therapy.
Yao M; Hao Y; Wang T; Xie M; Li H; Feng J; Feng L; Ma D
Front Neurol; 2023; 14():1149671. PubMed ID: 37025208
[TBL] [Abstract][Full Text] [Related]
35. [Relationship between glucose utilization by tissues and residual insulin secretion and their role in the genesis of hyperglycemia in type I diabetes mellitus].
Starostina EG; Lobanova AM; Magomedova AK
Probl Endokrinol (Mosk); 1992; 38(3):15-8. PubMed ID: 1513782
[TBL] [Abstract][Full Text] [Related]
36. Pathology testing of blood glucose levels.
Higgins C
Nurs Times; 1995 Jan 18-24; 91(3):42-4. PubMed ID: 7862559
[TBL] [Abstract][Full Text] [Related]
37. [Postprandial hyperglycemia. II. Pharmacological approaches].
Scheen AJ; Letiexhe MR; Geronooz I; Paquot N; Jandrain B
Rev Med Liege; 2002 Apr; 57(4):196-201. PubMed ID: 12073790
[TBL] [Abstract][Full Text] [Related]
38. Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.
Thrasher J
Am J Med; 2017 Jun; 130(6S):S4-S17. PubMed ID: 28526182
[TBL] [Abstract][Full Text] [Related]
39. Glucose kinetics: an update and novel insights into its regulation by glucagon and GLP-1.
Gastaldelli A; Gaggini M; DeFronzo R
Curr Opin Clin Nutr Metab Care; 2017 Jul; 20(4):300-309. PubMed ID: 28463898
[TBL] [Abstract][Full Text] [Related]
40. Practical implementation of incretin-based therapy in hospitalized patients with type 2 diabetes.
Schwartz SS; DeFronzo RA; Umpierrez GE
Postgrad Med; 2015 Mar; 127(2):251-7. PubMed ID: 25547241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
